ERBB2 and gastric cancer: Nevertheless, for GC, although several studies have reported liquid biopsy's efficacy in detecting disease and tracking therapeutic responses,41, 42, 43 the longitudinal plasma‐borne genomic details along with HER2‐targeted therapy remain largely uninvestigated.